Thrombosis and haemostasis - JoVE Visualize

Showing results (151-160 of 11,317) with videos related to

Pageof 1,132

Sort By:

Thrombosis and Haemostasis|January 17, 2003

Arterial intima-media thickness and its relationship with cardiovascular disease and atherosclerosis: a possible contribution of medium-sized arteriesP Bucciarelli, A Srámek, J H C Reiber, et al.

Thrombosis and Haemostasis|January 17, 2003

Combined effects of eptifibatide and anticoagulants: differences between LMWH and UH or rH in thrombin generation inhibition but not in platelet aggregation inhibitionMartin Koestenberger, Siegfried Gallistl, Gerhard Cvirn, et al.

Thrombosis and Haemostasis|January 17, 2003

Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiographyVerena Schroeder, Tushar Chatterjee, Haresh Mehta, et al.

Thrombosis and Haemostasis|January 17, 2003

Pathogenic effects of anti-glycoprotein Ib antibodies on megakaryocytes and plateletsGulie Alimardani, Josette Guichard, Serge Fichelson, et al.

Thrombosis and Haemostasis|January 17, 2003

Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domainsSybille Albrecht, Viktor Magdolen, Ute Herzog, et al.

Thrombosis and Haemostasis|December 7, 1992

Relationships between haemostatic factors and capillary morphology in human diabetic neuropathyI Ford, R A Malik, P G Newrick, et al.

Thrombosis and Haemostasis|December 7, 1992

Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbitD Carrie, C Caranobe, A M Gabaig, et al.

Thrombosis and Haemostasis|December 7, 1992

Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosisI Schwarzinger, M Stain-Kos, P Bettelheim, et al.

Thrombosis and Haemostasis|December 7, 1992

Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the finger domainH Yahara, K Matsumoto, H Maruyama, et al.

Thrombosis and Haemostasis|December 7, 1992

Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarctionF Andreotti, D R Hackett, A W Haider, et al.

Pageof 1,132

Showing results (151-160 of 11,317) with videos related to

Sort By:

Pageof 1,132

Thrombosis and Haemostasis|January 17, 2003

Arterial intima-media thickness and its relationship with cardiovascular disease and atherosclerosis: a possible contribution of medium-sized arteriesP Bucciarelli, A Srámek, J H C Reiber, et al.

Thrombosis and Haemostasis|January 17, 2003

Combined effects of eptifibatide and anticoagulants: differences between LMWH and UH or rH in thrombin generation inhibition but not in platelet aggregation inhibitionMartin Koestenberger, Siegfried Gallistl, Gerhard Cvirn, et al.

Thrombosis and Haemostasis|January 17, 2003

Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiographyVerena Schroeder, Tushar Chatterjee, Haresh Mehta, et al.

Thrombosis and Haemostasis|January 17, 2003

Pathogenic effects of anti-glycoprotein Ib antibodies on megakaryocytes and plateletsGulie Alimardani, Josette Guichard, Serge Fichelson, et al.

Thrombosis and Haemostasis|January 17, 2003

Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domainsSybille Albrecht, Viktor Magdolen, Ute Herzog, et al.

Thrombosis and Haemostasis|December 7, 1992

Relationships between haemostatic factors and capillary morphology in human diabetic neuropathyI Ford, R A Malik, P G Newrick, et al.

Thrombosis and Haemostasis|December 7, 1992

Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbitD Carrie, C Caranobe, A M Gabaig, et al.

Thrombosis and Haemostasis|December 7, 1992

Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosisI Schwarzinger, M Stain-Kos, P Bettelheim, et al.

Thrombosis and Haemostasis|December 7, 1992

Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the finger domainH Yahara, K Matsumoto, H Maruyama, et al.

Thrombosis and Haemostasis|December 7, 1992

Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarctionF Andreotti, D R Hackett, A W Haider, et al.

Pageof 1,132